© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
October 13, 2009
As is the case with a number of chronic, progressive neurologic disorders, there is a long running debate about whether pharmacotherapy modifies the course of Parkinson's Disease.
September 17, 2009
Prasugrel was recently approved by the FDA for a very narrow indication: Percutaneous coronary intervention patients with unstable angina, or MI with or without ST segment elevation.
September 10, 2009
It's clear that sleep deprivation impairs performance. However, data on persistent impairment from long working hours have been scarce, as most studies are cross-sectional.
August 19, 2009
Epilepsy is often a difficult disorder with which to live, as seizures are unpredictable and the consequences are potentially severe. The pharmacotherapy of epilepsy frequently entails a careful balance of drug dosing and timing, and anything upsetting this can lead to seizures or toxicity.
Jennifer Green, MD: Outcomes, Impact of SGLT2i, GLP-1 RA Combination Therapy
Joshua J. Joseph, MD: Managing CV Risk Factors in Patients with Type 2 Diabetes
Antirituximab Antibodies Detected in Patients with Pemphigus